Mariner Wealth Advisors »

Esperion Therapeutics shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $802k 303k 2.65
2023-09-30 $26k 26k 0.98
2023-06-30 $31k 22k 1.39
2022-12-31 $111k 18k 6.24
2022-09-30 $87k 13k 6.67

More positions owned by Mariner Wealth Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Broadcom (AVGO)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Mariner Wealth Advisors

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
PenderFund Capital Management
Geode Capital Management
State Street Corporation
Nuveen
AIGH Capital Management
Marshall Wace
Royce & Associates
Two Sigma Investments
Jane Street
Citadel Advisors
Two Sigma Advisers

View all funds holding Esperion Therapeutics